Ads
related to: gilead hiv drugs- Side Effects And Safety
Get Important Safety Information
About An HIV Medication.
- Learn How Treatment Works
Visit The Patient Website To Learn
How An HIV-1 Treatment Works.
- Talking To Your Doctor
Find Resources To Talk To Your
Doctor About An HIV-1 Therapy.
- Patient Assistance Info
Discover If You Are Eligible To
Save On An HIV-1 Treatment Option.
- Side Effects And Safety
Search results
Gilead (GILD) Up on Settling HIV Drug Suit With Generic Players
Zacks via Yahoo Finance· 2 years agoGilead (GILD) enters settlement agreements with a few generic manufacturers to resolve the...
FDA Approves Gilead's New HIV Treatment For Heavily Treated With Multi-Drug Resistant Patients
Benzinga via Yahoo Finance· 1 year agoThe FDA has approved Gilead Sciences Inc's (NASDAQ: GILD) Sunlenca (lenacapavir), in combination...
Gilead vs. CDC: The $1B Showdown Over HIV Drug Profits
Benzinga via Yahoo Finance· 1 year agoGilead Sciences Inc (NASDAQ: GILD) is reportedly looking to fight claims that it owes the U.S....
UPDATE 2-Gilead profit tops expectations despite lower COVID drug sales, outlook raised
Reuters via Yahoo Finance· 2 years agoGilead Sciences Inc on Thursday posted a higher-than-expected third-quarter profit on the back of...
Gilead Sciences: The Bull Case Is More Powerful Than You Think
GuruFocus.com via Yahoo Finance· 6 months agoGilead Sciences Inc. (NASDAQ:GILD) is an American pharmaceutical company specializing in developing...
Gilead expands FDA label for Biktarvy with Phase I pregnant HIV patient data
Clinical Trials Arena via Yahoo Finance· 1 month agoThe expanded approval of Gilead’s Biktarvy was based on the Phase I trial data showing efficacy in...
Clinics are losing funding for HIV prevention drugs and screenings. Here's what that means
Austin American-Statesman via Yahoo News· 1 year agoPreventing new HIV infections is becoming more difficult for nonprofit health clinics. Three things...
Gilead to buy CymaBay for $4.3 billion in bets on liver disease treatment
Reuters via Yahoo Finance· 4 months ago(Reuters) -Gilead Sciences has agreed to buy CymaBay Therapeutics for $4.3 billion, gaining access...
Buy Low, Hold Long: 2 Crushed Dividend Stocks To Buy For High Yields And Long-Term Gains
Benzinga via Yahoo Finance· 3 hours agoSuccessful companies sometimes face events that could affect their stock performance. However,...
Gilead (GILD) HIV Candidate Gets Positive CHMP Recommendation
Zacks via Yahoo Finance· 2 years agoGilead Sciences, Inc. GILD has announced that the Committee for Medicinal Products for Human Use...
Ads
related to: gilead hiv drugs